Latest in News & Research
Facial Vitiligo Area Scoring Index Reliable for Facial Involvement
Facial Vitiligo Area Scoring Index, using the fingertip unit, has high accuracy and intrarater reliability
By Dermsquared Editorial Team | | February 16, 2022
Short-Term Exposure to Air Pollution Linked to Psoriasis Flare
Air pollution may trigger psoriasis flares in individuals with chronic plaque psoriasis
By Physician’s Briefing Staff | | February 16, 2022
USPSTF Still Advises Syphilis Screening for At-Risk Teens, Adults
Grade A recommendation reaffirms 2016 recommendation for asymptomatic, nonpregnant adults and teens at increased risk
By Physician’s Briefing Staff | | February 15, 2022
Sleep Disturbance Highly Prevalent in Psoriasis Patients
Strongest predictors of sleep impairment include anxiety and depression levels, pruritus exacerbation at night, in morning
By Physician’s Briefing Staff | | February 15, 2022
Acral Lentiginous Melanoma Survival Varies by Race, SES
Differences in socioeconomic status contribute to survival disparities for Hispanic Black and White patients
By Physician’s Briefing Staff | | February 14, 2022
Persons With Homelessness Have Higher Odds of Group A Streptococcus SSTIs
However, first-line antibiotic coverage against MRSA more often given to persons experiencing homelessness
By Dermsquared Editorial Team | | February 09, 2022
Clinical Experts Develop Severity Scale for Alopecia Areata
Scale uses extent of scalp hair loss as primary basis for severity rating and includes four secondary features
By Dermsquared Editorial Team | | February 09, 2022
Twenty-Nine Novel Loci Identified for Acne Susceptibility
Meta-analysis of genome-wide association studies adds to knowledge of genetic contribution to acne susceptibility
By Physician’s Briefing Staff | | February 09, 2022
Knowledge of High Skin Cancer Risk Might Modify Risky Behaviors
Those at high risk of skin cancer accurately assessed risk and reported lower likelihood of future tanning bed use
By Physician's Briefing Staff | | February 08, 2022
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma
Overall survival longer in patients receiving first-line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone
By Physician’s Briefing Staff | | February 03, 2022
Which Treatment Is Most Efficacious for Male Androgenetic Alopecia?
Greatest increase in first end point of total hair count at 24 weeks was seen for 0.5 mg/day dutasteride
By Dermsquared Editorial Team | | February 02, 2022
How Does MMS Compare to Wide Local Excision for cSCC?
Mohs micrographic surgery is less expensive and results in 2.22 weeks of perfect health gained over five years versus WLE
By Dermsquared Editorial Team | | February 02, 2022
Metastases Occur in About 2 Percent of Cutaneous SCCs
Risk factors for metastases include age, male sex, and immunosuppression
By Physician's Briefing Staff | | February 01, 2022
Pfizer Will Ask FDA to Approve Its COVID-19 Vaccine for Children Under 5 Years
If approved, the two-shot regimen would become the first approved for use in children this young
By Physician’s Briefing Staff | | February 01, 2022
Novel Algorithm May Help Classify Skin Diseases
New algorithm uses multistage fusion process that includes clinical images, dermoscopy images, and patient meta-data
By Physician’s Briefing Staff | | January 31, 2022
Reporting of Race, Ethnicity Has Improved in Dermatology Trials
However, proportion of reporting articles including at least 20 percent non-White representation unchanged at 38.1 percent
By Dermsquared Editorial Team | | January 26, 2022
How Does Risankizumab Compare to Fumaric Acid Esters for Plaque Psoriasis?
Significantly more patients achieved ≥90 percent improvement in PASI at week 24 with risankizumab versus FAE
By Dermsquared Editorial Team | | January 26, 2022
Skyrizi Approved for Psoriatic Arthritis
Approval based on two Phase 3 trials showing more than 50 percent of patients receiving Skyrizi achieved ACR20 response at 24 weeks
By Physician’s Briefing Staff | | January 26, 2022
Self-Help Aids Quality of Life for People With Psoriasis
Findings show modest, but significant, benefit from either compassion-based or mindfulness-based self-help
By Physician’s Briefing Staff | | January 25, 2022
Risk for Cancer Increased After VTE for Patients With Psoriasis
Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years
By Physician’s Briefing Staff | | January 24, 2022
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
Increased market growth of biosimilars that are similar to brand-name biologic agents has the potential to reduce spending on prescription drugs
By Physician’s Briefing Staff | | January 21, 2022
Recommendations Updated for Recombinant Zoster Vaccine
By Physician’s Briefing Staff | | January 20, 2022
Is Electrical Impedance Spectroscopy Beneficial for Detecting Melanoma?
EIS increases diagnostic confidence for students and dermatologists assessing lesions clinically suspicious for melanoma
By Dermsquared Editorial Team | | January 19, 2022
24 of 1200
Headline from the Week of February 09 - 15, 2026
Second Annual National Cancer Database Report Presented for 2022
By Elana Gotkine (HealthDay News) | | February 11, 2026
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
By Elana Gotkine (HealthDay News) | | February 11, 2026